Multiple pro-inflammatory agents known to contribute to IBD, including cytokines IL-1β, TNF-α, and IFN-γ, as well as bacterial components such as LPS, were employed to establish an in vitro Caco-2 inflammation model (Figure 3). This evidence concerns the gene IL1B and inflammatory bowel disease.